For example, multiple loci related to the type I interferon pathway have been implicated in SLE disease activity by GWAS studies (Rice et al., 2017; Psarras et al., 2022) and gene signature modules of interferon-stimulated genes (ISG) have been shown to correlate with SLE disease activity. This evidence concerns the gene STING1 and systemic lupus erythematosus.